glp-1/gin medications GLP-1 for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness What to Make of the
Description
Taste changes are not listed among the common adverse reactions in the FDA prescribing information for semaglutide products, which primarily highlights gastrointestinal effects such as nausea, vomiting, and diarrhea
By activating GLP-1 receptors in the brain, semaglutide GLP-1 enhances the feeling of fullness after meals, making it easier to control hunger and reduce overall calorie consumption
The primary allegation in these lawsuits is that these drugs, which belong to a class called GLP-1 agonists, may cause severe gastrointestinal issues like gastroparesis (stomach paralysis), ileus (intestinal blockage), and other serious health problems
Acta Endocrinologica (Copenhagen) 1982;99:416421
Kathawas direct oversight
